Literature DB >> 15700155

[Evidence-based treatment of skin diseases caused by herpesvirus].

V Mahler1.   

Abstract

Six questions regarding varicella-zoster virus-related skin diseases are addressed. The Cochran Library, MEDLINE, Clinical Evidence and several guideline providers were searched for evidence. The level of evidence in papers was appraised according to the Oxford Centre for Evidence-based Medicine Levels of Evidence. The current evidence for antiviral therapy of chickenpox in immunocompetent children, adults and pregnancy, recommendation of varicella vaccination, effect of time of initiation of antiviral therapy in acute zoster as well as route of treatment with regard to onset of post-zoster neuralgia are covered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700155     DOI: 10.1007/s00105-005-0899-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  27 in total

1.  How to write an evidence-based clinical review article.

Authors:  Jay Siwek; Margaret L Gourlay; David C Slawson; Allen F Shaughnessy
Journal:  Am Fam Physician       Date:  2002-01-15       Impact factor: 3.292

2.  Controlled trial of acyclovir for chickenpox evaluating time of initiation and duration of therapy and viral resistance.

Authors:  H H Balfour; C K Edelman; R S Anderson; N V Reed; R M Slivken; L H Marmor; L Dix; D Aeppli; C L Talarico
Journal:  Pediatr Infect Dis J       Date:  2001-10       Impact factor: 2.129

3.  Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.

Authors:  B J Kuter; R E Weibel; H A Guess; H Matthews; D H Morton; B J Neff; P J Provost; B A Watson; S E Starr; S A Plotkin
Journal:  Vaccine       Date:  1991-09       Impact factor: 3.641

Review 4.  New antiviral agents for dermatologic disease.

Authors:  S Carlton; T Evans; S K Tyring
Journal:  Semin Cutan Med Surg       Date:  1998-12

5.  Acyclovir for treatment of postherpetic neuralgia: efficacy and pharmacokinetics.

Authors:  E P Acosta; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 6.  Rules of evidence and clinical recommendations for the management of patients.

Authors:  D L Sackett
Journal:  Can J Cardiol       Date:  1993 Jul-Aug       Impact factor: 5.223

7.  Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women.

Authors:  James H Harger; Joseph M Ernest; Gary R Thurnau; Atef Moawad; Valerija Momirova; Mark B Landon; Richard Paul; Menachem Miodovnik; Mitchell Dombrowski; Baha Sibai; Peter Van Dorsten
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

8.  Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia.

Authors:  Sawko W Wassilew; Peter Wutzler
Journal:  Antiviral Res       Date:  2003-06       Impact factor: 5.970

9.  Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials.

Authors:  M J Wood; R Kay; R H Dworkin; S J Soong; R J Whitley
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

Review 10.  Evidence-based medicine in a nutshell. A guide to finding and using the best evidence in caring for patients.

Authors:  M Bigby
Journal:  Arch Dermatol       Date:  1998-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.